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Abstract. Age-related changes in brain structure are a question of interest to a broad field of research. Structural decline has
been consistently, but not unambiguously, linked to functional consequences, including cognitive impairment and dementia.
One of the areas considered of crucial importance throughout this process is the medial temporal lobe, and primarily the
hippocampal region. Gender also has a considerable effect on volume deterioration of subcortical grey matter (GM) structures,
such as the hippocampus. The influence of age × gender interaction on disproportionate GM volume changes might be
mediated by hormonal effects on the brain. Hippocampal volume loss appears to become accelerated in the postmenopausal
period. This decline might have significant influences on neuroplasticity in the CA1 region of the hippocampus highly
vulnerable to pathological influences. Additionally, menopause has been associated with critical pathobiochemical changes
involved in neurodegeneration. The micro- and macrostructural alterations and consequent functional deterioration of critical
hippocampal regions might result in clinical cognitive impairment–especially if there already is a decline in the cognitive
reserve capacity. Several lines of potential vulnerability factors appear to interact in the menopausal period eventually leading
to cognitive decline, mild cognitive impairment, or Alzheimer’s disease. This focused review aims to delineate the influence
of unmodifiable risk factors of neurodegenerative processes, i.e., age and gender, on critical subcortical GM structures in
the light of brain derived estrogen effects. The menopausal period appears to be of key importance for the risk of cognitive
decline representing a time of special vulnerability for molecular, structural, and functional influences and offering only a
narrow window for potential protective effects.
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INTRODUCTION 30
Age-related changes in brain structure are a ques- 31
tion of interest to a number of different fields of 32
research including neuroendocrinology, neurobiol- 33
ogy, and neuroimaging, to just name a few. The 34
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growing body of research evidence has linked struc-35
tural alterations to certain functional and clinical36
manifestations, including dementia-related disor-37
ders. Dementia has become a major health and public38
concern worldwide with an increasing prevalence in39
the aged population. The most common cause of40
dementia in the general population above 60 years41
of age is Alzheimer’s disease (AD) [1]. AD is char-42
acterized by progressive behavioral, affective, social,43
and cognitive impairment [2]. The neuropathologi-44
cal changes presumed to stand behind the functional45
impairment are primarily the amyloid depositions and46
the neurofibrillary tangles [3, 4]. These histopatho-47
logical alterations have been described in several48
brain regions involving widespread frontal, pari-49
etal, and temporal cortical and subcortical structures.50
Among these, medial temporal subcortical structures51
are typically considered the most commonly empha-52
sized areas affected [5]. The most important risk53
factor of developing AD that cannot be influenced54
is age itself [6]. The most recent systematic review55
and meta-analysis on prevalence and incidence of56
dementia, and dementia due to AD found that increas-57
ing age was significantly associated with increasing58
prevalence and incidence rates of dementia [7] and59
AD [8]. Thus it appears crucial to understand the60
age-related changes occurring in brain structures of61
potential key importance. Large sample epidemio-62
logical studies show that women have a significantly63
higher risk of developing AD for various reasons64
(e.g., longer lifespan) [9–11]. Interestingly, incidence65
rates appear to show and age-dependent relationship66
between sex and likelihood of developing AD. Inci-67
dence of AD has been reported to increase with age68
for both sexes until about 85–90 years but to continue69
to increase among women only [12]. Therefore, gen-70
der is also considered a crucial unmodifiable factor71
in AD pathology with clear differences in structural72
and functional decline of specific brain areas.73
This review will be focusing on age and gen-74
der dependent changes in grey matter (GM) micro-75
and macrostructures–and especially subcortical GM76
formations—and related cognitive alterations as a77
functional representation in AD pathology.78
GREY MATTER ALTERATIONS79
IDENTIFIED IN AD80
A number of studies have addressed the neu-81
roanatomical changes in the background of clinical82
symptoms presenting in AD. A recent large sample83
meta-analysis has used anatomic likelihood estima- 84
tion aiming to identify more robust and consistent 85
alterations [5]. GM atrophy has been found to pri- 86
marily affect bilateral medial temporal lobe (MTL) 87
structures, involving the amygdala, hippocampus, 88
parahippocampal gyrus, uncus, and entorhinal cor- 89
tex, as well as the thalamus, caudate, and cingulate 90
cortices [13]. Strikingly, one significant cluster in 91
the left MTL has been identified as a potential 92
anatomical marker for AD development and pro- 93
gression. A robust GM loss has frequently been 94
documented in regions of the MTL bilaterally [14, 95
15]. Furthermore, the microstructure of the white 96
matter fibers in the close vicinity of the mediotem- 97
poral structures are also affected by the disease [16]. 98
Hypometabolism as measured by PET studies and 99
hypoactivation as revealed by functional MRI have 100
also been reported [17]. Disrupted functional connec- 101
tivity in these regions further supports the critical role 102
of MTL structures in the pathophysiology of AD [18, 103
19]. A main question of debate remains as to what 104
extent these changes reflect the course of the disease. 105
Research evidence indicates that relevant alterations 106
are present primarily in areas of the MTL several 107
years before the clinical signs of AD [20]. More- 108
over, morphological abnormalities and atrophy have 109
been detected in the left MTL specifically as the most 110
consistent structure to predict conversion from mild 111
cognitive impairment (MCI) to AD [21]. Thus, based 112
on the pattern of structural atrophy, the left MTL has 113
been suggested as a marker of disease progression in 114
AD [5] (for a summary of referenced findings please 115
see Table 1). 116
AGE-RELATED CHANGES OF RELEVANT 117
GM STRUCTURES 118
A great body of research evidence confirms that 119
aging is associated with decrease in total whole-brain 120
volume [22–24], overall GM and white matter (WM) 121
volume [25–29], as well as cortical thickness [30]. 122
It seems evident to state that, parallel to total brain 123
volume, the volume of subcortical brain structures in 124
general decreases with age. However, evidence indi- 125
cates that the changes are very different in specific 126
brain areas [31, 32]. Even studies reporting no overall 127
significant effect of aging on WM volume did reveal 128
a decline with age in some areas [26, 33]. 129
In order to understand the relevance of the 130
structural loss, we have to decipher their com- 131
plex neurobiological background and their effect 132
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Table 1
Age- and gender-related changes of medial temporal lobe, with the major focus on the hippocampus
Golomb et al., [160] Size of hippocampal formation predicts longitudinal alterations of performance on memory tests.
Murphy et al., [50] Larger age-related total GM volume loss and atrophy in frontal and temporal areas in males than in females,
Greater atrophy in females than in males in hippocampus and parietal cortices.
Hemispheric metabolic asymmetry in temporal and parietal cortices, Broca’s area, thalamus, and also in
hippocampus.
Raz et al., [43] Largest age-related decline: volume of the prefrontal cortices.
Slighter age-related alterations: volume of the fusiform gyri, inferior temporal, superior parietal areas.
Weak effects of age on hippocampus and postcentral gyrus.
Larger total brain volume and the hippocampus in males than in females.
Jack et al., [161] Annual decline in hippocampal volume, increase in temporal horn volume was identified in the elderly.
2.5 times greater rates in patients with AD than in age- and gender-matched controls.
Xu et al., [60] Larger atrophy with aging in right frontal lobe posteriorly in males compared to females.
Age-related atrophy in right temporal lobe medially, in parietal cortices, cerebellum + left basal ganglia in
males, but not in females. Smaller left thalamus, parietal, occipital cortices + cerebellum volume compared
to the right hemisphere.
No age- and gender-related difference in this asymmetry.
Good, et al., [26] Linear global GM volume loss with age, steeper decline in men.
Accelerated loss bilaterally in the insula, superior parietal gyrus, central sulcus + cingulum.
Little or no age effect in amygdala, hippocampus + entorhinal cortex.
Ge et al., [25] Constant GM volume loss, linearly with age throughout adulthood, whereas delayed WM volume loss until
midlife. No effect of sex.
Scahill et al., [24] Acceleration in atrophy with age in all analyses, prominently after the age of 70, particularly in the ventricles
and in the hippocampus.
Wang et al., [162] Distinct patterns of hippocampal shape alteration with age, different patterns of hippocampal volume loss
may distinguish mild dementia from healthy aging.
Sullivan et al., [52] Linear thalamic volume loss with age in a similar pace in males and females, whereas more steep cortical
GM volume decline during aging in men than in women.
Fleisher et al., [80] Greater deleterious effect of APOE*E4 genotype status on gross hippocampal pathology and memory
functions in women as compared to men.
Lemaitre et al., [55] Between the ages of 63 and 75 years, largest GM atrophy in primary cortices + in angular gyri, superior
parietal gyri, orbitofrontal cortex + in hippocampus. No sex × age interaction.
Ahsan et al., [42] Larger left caudate, nucleus accumbens + putamen, and larger globus pallidus in men.
Smith et al., [29] Relative regional differences in GM volume frontal, parietal + temporal cortices, no volume loss in medial
temporal lobe and in posterior cingulate. No gender effects.
Sowell et al., [30] Thicker right inferior parietal + posterior temporal cortices in females.
Gender differences in these areas are detectable from late childhood and are maintained throughout life.
Curiati et al., [35] Selective focus of accelerated GM reduction only in men, including temporal neocortices, prefrontal cortices,
and medial temporal areas.
Neufang et al., [65] Larger GM volumes of left amygdala in males, larger right striatal GM volumes and hippocampal GM
volumes bilaterally in females.
Independently of gender, volumes of amygdala and hippocampus are associated with levels of circulating
testosterone.
Ostby et al., [36] From childhood until adulthood: non-linear decrease in GM in cerebral cortex, linear decrease in caudate,
putamen, pallidum, nucleus accumbens, and cerebellum.
Small, non-linear increase in amygdala and hippocampal GM volume.
Ystad et al., [163] Hippocampal volumes are important predictors for memory function in elderly women.
Hemispheric asymmetry in hippocampal volumes during aging.
In females, volume of left hippocampus has predictive value.
Gender and left hippocampal volume may predict verbal memory performance in healthy elderly.
Erickson et al., [82] Limited time window for hormone replacement therapy to positively influence hippocampal volume.
Fjell and Walhovd, Heterogeneous pattern in the atrophy of specific brain areas during aging: largest shrinking in frontal and
temporal cortices + in putamen, thalamus, and nucleus accumbens.2010 [38]
Mukai et al., [77] Important role of hippocampus-derived estradiol in the modulation of synaptic plasticity.
Goto et al., [83] Reduced GM volume in bilateral hippocampus in females in their fifties (most of them experiencing
menopause) compared to females in their forties (most of them not experiencing menopause).
→ Menopause may correlate with reduction of hippocampal volume.
Skup et al., [45] Different patterns of decline with age in males and females in AD group and MCI group compared to healthy
controls in precuneus and caudate nucleus bilaterally, right entorhinal gyrus, thalamus bilaterally, left
insula, and also in right amygdala.
Takahashi et al., [51] More retained GM concentrations in females during aging in inferior frontal gyri bilaterally, cingulate gyrus
anteriorly, hypothalamus and in medial thalamus.
(Continued)
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Table 1
(Continued)
Devanand et al., [164] Differences in volumes of hippocampus, entorhinal cortex, and parahippocampal gyrus between MCI and
healthy controls.
In patients converting from healthy to MCI: larger atrophy in the head of hippocampus, specifically in CA1 and
subiculum, in entorhinal cortex, especially in bilateral pole of EC.
Borghesani et al., [165] Improvement of midlife memory positively correlates with larger hippocampal volume in the elderly, compared
to those who had decline or no change in their episodic memory in their midlife.
Ooishi et al., [78] Crucial role of hippocampus-derived estradiol, T, and DHT in modulating synaptic plasticity.
Rijpkema et al., [53] No gender difference in caudate nucleus and nucleus accumbens.
Larger globus pallidus and putamen volume.
Spencer-Segal et al., [79] In females, important role of estrogen receptor signaling in hormone’s influence regarding hippocampal synaptic
plasticity.
Fjell et al., [34] Faster estimated decline in the elderly in hippocampus.
Taki et al., [166] Positive correlations between yearly regional GM volume alterations and age: temporal pole bilaterally, caudate
nucleus, insula, hippocampus.
Negative correlations between age and changes in cingulate gyri bilaterally + cerebellum.
Age × gender interaction between annual ratio of regional GM volume change in hippocampus bilaterally.
Crivello et al., [167] Higher GM decline in females compared to males (persistent throughout age ranges)
Hippocampus: similarly accelerated decline with age in males and females.
Li et al., [58] Age-related atrophy in basal ganglia and thalamus.
Hippocampus atrophy in males only, and no decline in the amygdala.
Perlaki et al., [57] No sexual dimorphism in the size of hippocampus.
Kiraly et al., [56] Larger hippocampus volume in females.
Age-related decrease of caudate nucleus, putamen and thalamic volumes in males.
Thalamic volume loss in females.
Faster decrease in total GM volume in males as compared to females.
on functionality. Fjell and his co-workers have133
done tremendous work in an effort to character-134
ize cross-sectional and longitudinal changes in brain135
aging and to compare healthy normal aging to136
pathological alterations (i.e., the Alzheimer Disease137
Neuroimaging Initiative) [34]. Fjell et al. have used138
a nonparametric smoothing spline approach to assess139
age trajectories of anatomical structures in a large140
sample of healthy adults. Cross-sectional as well as141
longitudinal, follow-up data has been analyzed iden-142
tifying certain critical age periods. These critical ages143
would account for a more significant rate of change144
within the estimated range of volume loss. Latter145
has been described for total brain volume with a146
stronger correlation above the age of 60, as well as147
for the cerebral cortex, and, interestingly the pal-148
lidum, with the age of around 25 years correlating149
most with structural decline. A linear reduction with150
age has been identified for a number of subcortical151
structures, i.e., the amygdala, nucleus accumbens,152
putamen, and the thalamus, also supported by sev-153
eral previous findings [31, 35]. The hippocampus has154
been previously characterized by a nonlinear pat-155
tern of estimated change through adulthood. This156
might be explained by a prolonged phase of devel-157
opment [36], a longer stable period and, critically,158
an accelerated volume loss starting around the age159
of 50 and an even more robust negative relation- 160
ship above 60 [37–39]. Indeed, in the longitudinal 161
analysis, the hippocampus showed the fastest rate 162
of volume reduction (–0.83% per year) among sub- 163
cortical structures [34]. Changes in brain volume 164
constitute a truly dynamic process with a great num- 165
ber of potential influencing factors, which should be 166
ideally monitored by using longitudinal approaches 167
with a high density of assessments. Nevertheless, 168
more complex and sophisticated methods of analysis 169
as well as large volume data could yield more insight 170
into targeted questions [40]. 171
Another highly dynamic process throughout the 172
human lifespan is considered the interaction with and 173
accommodation of constant endogenous and exoge- 174
nous influences. The view of lifespan trajectories of 175
change in brain structure and function might serve as 176
a base of understanding vulnerability to certain age- 177
related disorders such as MCI and AD. It might be 178
crucial to emphasize the potential significance of life 179
course effects which, in a complex interaction, will 180
eventually separate dementia and cognitive decline 181
from normal aging-related mechanisms. However, it 182
also appears that the relationship between different 183
exogenous and endogenous events and their impact 184
on brain structure and function varies in importance 185
in the light of the time of their occurrence [41]. 186
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GENDER-RELATED CHANGES OF187
RELEVANT GM STRUCTURES188
Sexual dimorphism of the human brain anatomy189
has gained increasing interest, with subcortical GM190
structures also being investigated more widely [42].191
A number of studies have addressed the combined192
effects of age and gender on human brain structures.193
A more profound decline in GM volume has been194
described in males [33, 43, 44]. However, in patients195
with MCI and AD, GM volume has been found to196
decline faster in females as compared to males sup-197
porting the evidence of faster progression from MCI198
to AD [45]. This might be related to the main dif-199
ference in brain anatomy between sexes, i.e., brain200
size. A larger brain might well have a greater reserve201
capacity to withstand pathology at the same level of202
functionalilty and cognitive abilities [46]. This has203
also been underlined by autopsy studies reporting204
women to have significantly higher odds of a clin-205
ical diagnosis of AD at the same level of neuronal206
pathology [47].207
The effect of gender on the volume of these208
structures might be crucial, considering that basal209
ganglia possess a high density of sex steroid receptors210
[48]. However, neuroimaging results on the gender211
dependent volume of subcortical GM are somewhat212
contradictory. Some studies reported larger volumes213
of the caudate nuclei [49], hippocampus [50], and214
thalamus in females [51], while others had oppos-215
ing results [52, 53]. The amygdala [54], pallidum,216
and the putamen [53] have been consistently found217
to be larger in males. Thus, research evidence appears218
inconsistent especially considering the subcortical219
GM structure [55]. This might also be due to the220
method of analysis, considering the difficulty to221
delineate subcortical GM using conventional voxel222
based morphometric methods. Our research group223
has applied a deformable surface model based seg-224
mentation approach to address volumetric alterations225
especially in regions with low tissue contrast [56].226
While age, gender, and head size (intracranial vol-227
ume) are the most commonly included ‘nuisance’228
variables when performing neuroimaging analysis,229
studies vary as to which of these variables are230
included and which method is used for correction231
[57]. These factors might widely account for the232
great variability in the results. Accounting for skull233
size significantly influences results when it comes to234
GM volume and it might be of even greater impor-235
tance when considering differences between males236
and females. Our results revealed larger cortical and 237
subcortical GM volume for females as a result of 238
correction for total intracranial volume in a study 239
involving 103 participants in the age range of 21–58 240
years. The volume of the hippocampus was found sig- 241
nificantly larger in the female group as compared to 242
males. We also detected a significant effect of hemi- 243
sphere in the male group only, with larger volumes of 244
the right caudate and the left thalamus as compared 245
to their contralateral structures. 246
Interestingly, we also found an age-dependent 247
decrease in the volume of cortical as well as subcor- 248
tical GM. Latter remained significant after correction 249
for skull size in the caudate, putamen, and thalamus 250
bilaterally for males and the thalamus bilaterally for 251
females. Within the age range of 21 to 58 years, we 252
found a linear decrease in GM volume with aging. 253
Strikingly, this process proved to occur at a faster pace 254
in males. Converging research evidence emphasizes 255
the importance of considering age and sex interaction 256
effects on the volumetric decline of subcortical struc- 257
tures. Li and his colleagues found this to be of key 258
relevance for the hippocampus specifically, showing 259
a linear negative correlation with age for males only 260
[58]. Strikingly, for females, the pace of hippocam- 261
pal volume decline has been found to occur at an even 262
slower pace than whole brain volume loss. In contrast 263
with this, a strong effect of aging on basal ganglia 264
and thalamus volume changes has been observed pri- 265
marily for females. The authors link these results 266
to functional consequences involving predominantly 267
psychomotor performance especially at later ages 268
[59–61]. However, a number of studies did not find a 269
significant effect of gender on cognitive performance 270
or decline with age [62, 63]. While directly link- 271
ing functional aspects to structural changes in brain 272
anatomy might not be equivocal, elucidating effects 273
of age × sex interaction on specific subcortical GM 274
regions might well serve the investigation of related 275
psychopathological alterations, such as MCI or AD. 276
The background of the disproportionate GM vol- 277
ume changes has not yet been elucidated, but the 278
changes in hormone levels and the consequent 279
sensitivity of the brain to hormonal effects are 280
most certainly involved [64]. Sex hormones have 281
been found to critically influence regional matu- 282
ration of subcortical GM structures, e.g., higher 283
circulating testosterone levels correlated positively 284
with amygdala volume and negatively with hip- 285
pocampal volume [65]. Estrogen among androgens 286
has gained significant interest for its crucial role
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during brain development. Females with endogenous287
estrogen deficiency have been found to have dis-288
proportionately reduced hippocampal volumes and289
increased amygdala volume as compared to age-290
matched controls [66]. This might be related to the291
complex distribution of estrogen receptors through-292
out the brain. Distinct estrogen receptor subtypes293
have been identified in nearly all cell types of the294
central nervous system, and importantly, in brain295
regions typically associated with cognitive func-296
tion such as memory and affective processing, e.g.,297
the amygdala and the hippocampus [67]. Strikingly,298
the estrogen-related volume deficiency evidenced by299
structural neuroimaging has also been associated300
with functional consequences revealed by cognitive301
assessment [68].302
Epidemiological results support the notion that303
age-related loss of steroid hormones is associ-304
ated with an increasing risk to develop AD [69].305
Above this, AD prevalence is higher in post-306
menopausal women as compared to age-matched307
men–not explained by the generally higher life308
expectancy for females [70, 71]. The crucial role of309
estrogen is supported by several lines of evidence,310
with early menopause having been associated with311
an increased prevalence of dementia [72]. Estro-312
gen has been found to modulate neurogenesis and313
activation of new neurons in response to targeted cog-314
nitive demands in the hippocampus [73, 74]. This315
might be mostly dependent on brain derived estra-316
diol concentration [75], suggesting the importance317
of neuronal, and especially hippocampal, estrogen318
production [76]. Estrogen has a potent effect on319
inducing neurogenesis, neuronal morphology, and320
plasticity in specific areas of the hippocampus,321
such as the CA1 region and the dentate gyrus [74,322
77–79]. An association between estrogen deficiency323
and hippocampal volume loss in females with clin-324
ically diagnosed MCI [80] might well serve as a325
potential common course leading to AD. However,326
there might be another crucial aspect, which should327
be emphasized when considering neuronal estro-328
gen related hippocampus structure and fun tion. A329
significant sex hormone cycle related effect on spe-330
cific cognitive performance has only been found331
during initial testing and disappeared with repeated332
examinations of the same parameter, controlling for333
other confounding factors [81]. This occurred dur-334
ing an 8-week long testing period, which raises335
interesting questions about a life course perspec-336
tive of hippocampus-related cognitive performance337
and the risks of consequent dementia. Furthermore,338
hormone treatment effects on the hippocampus 339
in post menopause detected a limited window of 340
opportunity to influence hippocampal volume. How- 341
ever, the larger hippocampal volumes associated 342
with hormone treatment initiated at the time of 343
menopause did not translate to improved cognitive 344
performance [82]. 345
Hippocampal volume loss appears to become 346
accelerated in the postmenopausal period [83], 347
which, associated with brain estrogen production 348
decline, might be due to a significant reduction in neu- 349
ronal plasticity primarily in the CA1 region. While 350
postmenopausal hormone replacement therapy might 351
spare the total hippocampal volume in a limited win- 352
dow of action, this might not be effective on the key 353
areas of neuroproliferation. Consecutively, cognitive 354
performance is not affected beneficially, eventually 355
leading to the development of MCI or AD, due to 356
the impaired cognitive reserve abilities influenced by 357
several other factors (Fig. 1). 358
FUNCTIONAL CONSEQUENCES OF GM 359
CHANGES RELEVANT FOR DEMENTIA 360
OCCURANCE 361
Above the structural differences, there is increas- 362
ing evidence for the functional sexual dimorphism of 363
subcortical structures. Hippocampus-related memory 364
functions are differently affected by stress in males 365
and females [84]. Peripartum hormonal changes are 366
known to modulate the hippocampal function [85]. In 367
addition to gender effects, recent evidence supports 368
the influence of brain hemisphere showing lateral- 369
ization of structure-function relationships, as well as 370
more specific relationships between individual struc- 371
tures (e.g., left hippocampus) and functions relevant 372
to particular aptitudes (e.g., vocabulary) [86]. Numer- 373
ous differences between the cognitive patterns of the 374
two sexes have been reported [87]. Estrogen and 375
testosterone appear to play a significant and contin- 376
uous role in cognition throughout the lifespan [58]. 377
In puberty, adolescents who mature later have better 378
visuospatial skills than those who mature earlier [88]. 379
Furthermore, a longer reproductive period is associ- 380
ated with higher levels of verbal fluency later during 381
adulthood [89]. In adulthood, certain differences 382
between male and female cognitive features are well 383
known, e.g., higher performance on visuospatial tasks 384
in males and female advantage in verbal skills [90]. 385
This characteristic pattern of different cognitive abil- 386
ities appears to persist later in life [91]. Interestingly, 387
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Fig. 1. According to major communication pathways of the hippocampal circuit multisensory input information enters primarily the entorhinal
cortex (EC) then projecting towards the dentate gyrus (DG) and the CA3. Pyramidal cells of the CA3 send their axons to the CA1, which
then projects to deep layers of the EC and sends the selected information along the output paths of the hippocampus. Additionally, feedback
is being provided to the EC. The postmenopausal period and related estrogen loss might be associated with changes in the neuroplastic
capacity of especially vulnerable regions of the hippocampus, such as the CA1 region. This region is rich in brain derived estrogen receptors
and represents a key area for estrogen related neuronal manifestations. Molecular and pathobiochemical alterations might be present in
the background of this deterioration, i.e., mitochondria-related inflammatory, oxidative effects. As a consequence, the selection of relevant
information might become impaired or completely altered. In addition, the feedback source of the EC representing the major multisensory
input area also becomes disturbed or even absent. In the presence of an impaired cognitive reserve capacity related to several previous internal
and external factors, this might be an especially vulnerable time window for hippocampal structural and functional decline. This could result
in an accelerated volume loss of the hippocampus and presumably, a consequent significant cognitive decline.
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cognitive skills of women tend to decline slower388
than those of men [92]. Estrogen has been389
suggested as a protective factor against dementia390
through facilitating neurogenesis in the hippocam-391
pus and thus enhancing hippocampus-related spatial392
learning and aspects of memory [74].393
Distinguished patterns of cognitive skills were con-394
firmed not only in healthy aging, but also in patients395
with AD. Assessing AD patient’s verbal skills, a396
meta-analysis revealed a difference in naming tasks397
and semantic fluency with lower performance in398
women [93]. As to visuospatial skills, no significant399
difference was found between women and men with400
AD [94]. Based on another meta-analysis assessing401
global dementia severity in men and women, it was402
found that women reached a significantly lower score403
compared to men with AD [95].404
Apart from the individual’s sex and its hormonal405
influences on cognition through the lifespan, other406
contributing factors might enhance or prevent cogni-407
tive decline and developing AD. According to a recent408
cohort study, lower performance in school during409
childhood may increase the risk for cognitive decline410
in later life [96]. Greater midlife stress is associated411
with a higher risk to develop dementia, especially412
AD among women [97]. Strongly negative life events413
such as losing a close relative can also increase vul-414
nerability to enhance cognitive decline along with415
depression; however, milder but chronic stress factors416
may even stimulate cognitive functioning [98].417
Brain areas typically affected in MCI and AD418
have a specific hierarchical order in which they419
become altered during the course of the disease based420
on Braak and Braak’s neuropathological model [3].421
According to this model, the first lesions can be422
detected in the MTL, including the hippocampus,423
parahippocampus, and crucial areas of the limbic424
circle, e.g., the amygdala, then in several areas of425
the temporal lobe, followed by other regions of the426
neocortex. The affected structures have their distinct427
roles in cognition; however, they contribute alto-428
gether to the characteristic clinical manifestation of429
AD. As an example of key importance, higher visual430
perception, including identification and recognition431
of faces and landmarks, as well as recognition of432
facial emotions, is dependent on the medial temporal433
lobe structures [99]. The impairment of these abili-434
ties might have an impact on behavioral disturbances435
in early AD and might even serve early identification436
of AD [100].437
Being a key structure of the MTL and its memory438
network, the integrity of the hippocampus is required439
not only in episodic and semantic memory, but also 440
in spatial information processing and manipulation 441
[101]. The reduced ability to retain new information is 442
one of the earliest core features of dementia and con- 443
stitutes a heavy burden on the daily life of patients and 444
caregivers [102]. A significant correlation of reduced 445
hippocampal volume combined with higher levels 446
of cortisol and performance on auditory and ver- 447
bal memory subtests of the Wechsler’s Intelligence 448
Scale and Block Design tests measuring visuospa- 449
tial skills has also been reported [103]. A recent 450
study describes decreased thickness of the hippocam- 451
pal GM formation in AD as compared to healthy 452
individuals or patients with MCI [104]. Considering 453
that scores on the Mini-Mental State Examination 454
(MMSE) and the Alzheimer’s Disease Assessment 455
Scale-Cognition (ADAS-Cog) correlate with base- 456
line entorhinal cortex thickness, its atrophy might 457
be a predictor of subsequent cognitive impairment. 458
The atrophy of hippocampal areas has been asso- 459
ciated with more severe deficits in several aspects 460
memory (especially episodic memory) and execu- 461
tive function [105]. Associated with lower activity 462
in these areas, AD patients have demonstrated poorer 463
encoding and retrieval than healthy individuals [106]. 464
Simultaneously, increased activation in ventral lateral 465
prefrontal areas may be interpreted as a compensatory 466
mechanism in AD. 467
When considering the broader picture of cogni- 468
tive disturbances already detectable in early stages 469
of dementia, several other areas need to be men- 470
tioned. The thalamus, as a key area of the limbic 471
circuit and the episodic memory network, has also 472
been reported to be affected in early stage AD [107]. 473
Alterations of the amygdala appear to have a pro- 474
found effect on emotional aspects of memory in AD 475
[108, 109]. Emotional stimuli, especially those with 476
negative valence, have altered influence on memory 477
functions in AD patients [110] and amygdala atrophy 478
has been correlated positively with emotional mem- 479
ory impairment severity [111]. Some recent studies 480
even pointed out other complex functions of the MTL, 481
including path integration, e.g., spatial representa- 482
tion, self-motion sensing, and temporal processing 483
[112]. Lesions of the anterior areas of the hippocam- 484
pus, parahippocampus, amygdala, and the anterior 485
and lateral section of temporal gyrus are associated 486
with poor performance on tests of delayed memory, 487
long-term memory and spatial memory. Addition- 488
ally, patients with alterations of these structures 489
have difficulties in target-directed walking because of 490
deficits of allocentric spatial information processing. 491
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The picture is certainly much more complex and it492
becomes increasingly difficult to decipher a causal493
relationship. Nevertheless, the role of the hippocam-494
pal region appears to be crucial in the occurrence and495
progression of the cognitive impairment in MCI and496
AD.497
It is debated whether the extent of MTL structural498
atrophy is a better predictor of clinical dementia as499
compared to the memory deficit. Some studies found500
that the ratio of amygdala volume loss and bilat-501
eral entorhinal cortex shrinkage predicted time until502
MCI symptom occurrence [113]. Others, for example503
Visser et al., reported scores on cognitive test batter-504
ies to serve as better predictors than MTL atrophy in505
a longitudinal study design [114].506
Considering that the volume of subcortical GM507
critically impacts the size of neurons, glia cells, and508
number of synapses it entails, we might hypothesis509
that it affects the function and performance of these510
structures. While deducing cognitive or any other511
type of functional activity of subcortical GM solely512
from their structural characteristics would be inad-513
missibly simplified, observing changes in volume of514
subcortical GM influenced by gender and aging might515
yield better insight into several pathological condi-516
tions, e.g., MCI and AD [115].517
TRANSITION FROM HEALTHY AGING518
TO MILD COGNITIVE IMPAIRMENT519
AND AD520
MCI is considered a precursor stage of AD with an521
annual conversion rate of approximately 15% [116].522
However, the clinical manifestation of MCI is still523
not considered a predestination of a future conver-524
sion to AD. One of the crucial biomarkers proposed525
in the aim of a more valid diagnostic construct is526
MTL atrophy [117]. A large number of studies have527
focused on hippocampal volume loss focusing on528
MCI conversion to AD reporting a non-uniform pat-529
tern of hippocampal shrinkage. Converging research530
evidence emphasizes the key role of the CA1 region531
and subiculum showing the most significant involve-532
ment throughout disease progression early on in the533
course of illness [118–124]. While hippocampus vol-534
ume has been reported to hold the highest predictive535
accuracy for conversion to AD, the best multivariate536
model for AD prediction, interestingly, consisted of537
cognitive variables only [125].538
A potential explanation for this seeming discrep-539
ancy might be related to methods of imaging analysis540
with more advanced techniques needed to ascertain 541
reliable and accurate data processing. The radial atro- 542
phy technique used to investigate subtle changes in 543
distinct regions of the hippocampus might be a useful 544
method in addressing prominent volume loss prior to 545
clinical pathology. Here, the CA1 region might be of 546
crucial importance, considering its robust volumet- 547
ric loss above the age of 60 also compared to other 548
regions of the hippocampus. However, if this is true 549
for the normal aging process, what could then be the 550
key turning point that eventually leads to the outcome 551
of dementia? 552
A view that gains increasing support offers an 553
explanation relying on neuroplasticity. Brain regions 554
characterized by high neuroplasticity have been 555
found to be especially vulnerable to neurodegen- 556
eration as well [126–128]. The CA1 region of the 557
hippocampus maintains its neuroplastic flexibility 558
well into adulthood presumably serving cognitive 559
capacity in interaction with external and internal 560
demands. Converging evidence supports the finding 561
that high level abilities of neuroplasticity are retained 562
late in life [129–131], especially in areas with long 563
axonal connections, such as the hippocampal region 564
[127]. The neurons in these regions might be able 565
to maintain their morphological and functional flex- 566
ibility to serve cognitive processes, however, these 567
abilities might on the other hand increase their vul- 568
nerability to neurotoxic effects eventually resulting 569
in structural and functional decline [132, 133]. The 570
hippocampal region is undoubtedly a key area for 571
high-order cognitive processes, such as memory and 572
learning, associated with high demands for neu- 573
roplasticity and neuronal flexibility [134, 135]. In 574
addition to this, other neuronal morphological pro- 575
cesses, such as dendritic spine plasticity, might also 576
play a crucial role in cognitive flexibility through- 577
out the lifespan [136]. This mechanism might be 578
involved in cognitive processes related to the CA1 579
region of the hippocampus [137, 138]. However, 580
this might also be a vulnerability component for 581
pathological effects, i.e., disturbed neurogenesis and 582
neuronal flexibility in the hippocampus has been 583
suggested as a crucial early component in cog- 584
nitive decline and even AD [139]. The relatively 585
rapid structural decline observed in postmenopausal 586
women in these vulnerable regions might further 587
accelerate the deterioration resulting in a vicious 588
circle [140]. This is supported by findings of 589
an age × gender × subcortical structural dependent 590
interaction with an impact on cognitive reserve abil- 591
ities [141].
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RELEVANT MICROSTRUCTURAL AND592
PATHOBIOCHEMICAL CHANGES IN THE593
BACKGROUND OF STRUCTURAL AND594
FUNCTIONAL DETERIORATION595
In the light of the presumably impaired neuro-596
plasticity consequently leading to macrostructural597
changes in the hippocampal formation, one has to598
certainly address the microstructural neuropathology599
behind it. Focusing on specific hormonal effects, it600
has been shown that neuronal substrates associated601
with cognitive decline are significantly impacted by602
estrogens [142]. Research evidence indicates that603
most of estrogens’ neuronal effects are related to604
brain derived estrogen, synthetized within the cen-605
tral nervous system [143, 144]. While levels of brain606
estrogen might largely differ from that of circu-607
lating estrogen, female brain estrogen levels have608
been found to relate well with blood estrogen lev-609
els measurable on the periphery [145]. Strikingly, a610
significant decline in brain-derived estrogen charac-611
terizes the postmenopausal period. It has also been612
suggested that this decline occurs mainly around613
menopause and, paired with a significant reduction614
in brain derived estrogen synthesis, it might lead to615
consequent cognitive deterioration [146, 147]. One616
key neuronal substrate that integrates several estrogen617
regulated molecular pathways is the mitochondria618
[148–150]. Estrogen receptors have been found in619
the mitochondria and the key role of mitochondria620
in estrogen associated neuroprotection has been sup-621
ported by several different lines of evidence involving622
anti-inflammatory actions, anti-oxidant effects, and623
glutamate-related mechanisms among others (for an624
excellent review, see [151]). New evidence also625
indicates that a mitochondrial estrogen receptor defi-626
ciency found in the female AD brain results in627
impaired anti-inflammatory and anti-oxidative capac-628
ity of the mitochondria indicating vulnerability for629
neurodegeneration [152]. Our research has focused630
on the mitochondrial disturbances critical in aging,631
neurodegeneration, and AD specifically also involv-632
ing the kynurenine system [153–155], glutamatergic633
mechanisms [156], and bioenergetic effects [157].634
The complex interaction of these processes might635
well serve as a pathobiochemical and molecular636
background for the structural and functional alter-637
ation described in neurodegeneration. This is also638
supported by the relationship between worse patho-639
logical changes (i.e., amyloid depositions and total640
tau levels) and a more rapid hippocampal atrophy and641
cognitive decline in females, marking a potentially642
increased vulnerability for the clinical manifesta- 643
tions of MCI and AD [158]. In the female brain, 644
the menopausal period brings deterioration in the 645
above mentioned bioenergetical balance with a poten- 646
tial lack of compensatory mechanisms representing a 647
vulnerability to cognitive decline [159]. 648
CONCLUDING REMARKS 649
AD is a growing healthcare issue worldwide 650
demanding more and more precise characterization 651
and identification of potential turning points from 652
healthy aging to MCI and AD. An increasing body of 653
research evidence has confirmed specific subcortical 654
GM alterations in the brain during this process, evolv- 655
ing based on a hierarchical model. The firstly affected 656
and most crucial areas are the components of MTL, 657
especially the hippocampus. Endogenous and exoge- 658
nous factors interacting with each other contribute to 659
continuous alterations of these areas from our birth 660
throughout adulthood. There are non-modifiable vari- 661
ables, such as age and gender, which have specific 662
effects during aging, involving hormonal influence. 663
In women, hippocampal volume loss appears to be 664
accelerated in the postmenopausal period. This vol- 665
ume loss might be associated significantly and in a 666
beginning stage with the neuroplasticity of the CA1 667
region in hippocampus, considering its high sensi- 668
tivity to pathological alterations. The atrophy and 669
consequent structural decline and functional impair- 670
ment of this region evolving to other hippocampal 671
and MTL areas might lead to the clinical manifes- 672
tation of cognitive decline. This risk might be the 673
greatest in the case of an already narrowed cognitive 674
reserve capacity or subclinical cognitive impairment. 675
Serving as a potential biomarker, specific structural 676
hippocampal changes might be associated with con- 677
sequent functional patterns of cognition, potentially 678
supporting the identification of MCI and AD prior to 679
the clinical symptoms of the disease. The interaction 680
of age and gender combined with individual variables 681
such brain-derived estrogen receptors, bioenergetical 682
balance, and compensatory mechanisms should be 683
taken altogether into consideration when assessing a 684
potential occurrence of MCI and AD. 685
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